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Introduction
Loss-of-function mutations in the IL36RN gene define a
novel recessively inherited autoinflammatory syndrome
named deficiency of IL-36 receptor antagonist (DITRA).
This genetically determined deficiency was first
described in a subgroup of patients with generalized
pustular psoriasis. It is a life-threatening condition char-
acterized by recurrent episodes of severe skin inflamma-
tion, with pustule development, associated with fever,
malaise, extracutaneous involvement, neutrophilia and a
marked acute phase response.
Case report
Methods
The patients’ data as well as the outcome of the admi-
nistered treatments were collected from charts reviews.
IL36RN analysis was performed by means of Sanger-
based sequencing.
Results
We describe two unrelated families with patients diag-
nosed as suffering from generalized pustular psoriasis.
The family 1 is a large consanguineous Algerian family
with several affected members living in Algeria and in
Spain. The propositus is a 13 year-old child who had
suffered from two episodes of severe skin inflammation,
with disseminated pustular development and systemic
features that required hospital admission. Once DITRA
was described in 2011, this diagnosis was suggested for
this patient. IL36RN mutational analyses revealed a
homozygous T-to-C transition in the exon 3 (at c.80
position), which provokes the leucine-to-proline variant
at residue 27 (p.L27P) of the protein. This missense
variant has been previously identified as a true disease-
causing mutation in other Maghrebian (Tunisian)
families with DITRA.
The family 2 is an apparent non-consanguineous
Spanish family with only one affected individual. The
patient is a 15 years-old girl who suffered since 6
months of age from recurrent and severe episodes of
generalized pustular psoriasis that required recurrent
hospital admissions. She has been treated with different
drugs, including methotrexate, acitretin, cyclosporin,
phototherapy, etanercept, infliximab, adalimumab and
ustekinumab, with variable and limited efficacy. As a
DITRA diagnosis was suggested, IL36RN analysis was
performed. This study revealed an apparent homozygous
7 bp deletion in the exon 5 (c.420_426del), which
should provoke a frameshift of the normal open reading
frame. Genetic studies are currently ongoing to elucidate
the intrafamilial mutational segregation pattern.
Discussion
We describe two novel families affected by the novel
autoinflammatory disease called DITRA. The disease
started in these patients during childhood as severe
episodes of generalized pustular skin rash and systemic
features that required hospital admissions. We identified
a novel IL36RN mutation in the Spanish family, and the
already known missense p.L27P mutation in the Alger-
ian family. This insight probably expands the founder
effect of this IL36RN mutation to other Maghrebian
populations than Tunisian people.
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